Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 7854745 was granted and assigned to Obalon Therapeutics on December, 2010 by the United States Patent and Trademark Office. | 7854745 | December 21, 2010 | |||||||
Patent 8202291 was granted and assigned to Obalon Therapeutics on June, 2012 by the United States Patent and Trademark Office. | 8202291 | June 19, 2012 | |||||||
Patent 9539132 was granted and assigned to Obalon Therapeutics on January, 2017 by the United States Patent and Trademark Office. | 9539132 | January 10, 2017 | |||||||
Patent 8162969 was granted and assigned to Obalon Therapeutics on April, 2012 by the United States Patent and Trademark Office. | 8162969 | April 24, 2012 | |||||||
Patent 10327936 was granted and assigned to Obalon Therapeutics on June, 2019 by the United States Patent and Trademark Office. | 10327936 | June 25, 2019 | |||||||
Patent 10350100 was granted and assigned to Obalon Therapeutics on July, 2019 by the United States Patent and Trademark Office. | 10350100 | July 16, 2019 | |||||||
Patent 10335303 was granted and assigned to Obalon Therapeutics on July, 2019 by the United States Patent and Trademark Office. | 10335303 | July 2, 2019 | |||||||
Patent 9072583 was granted and assigned to Obalon Therapeutics on July, 2015 by the United States Patent and Trademark Office. | 9072583 | July 7, 2015 | |||||||
Patent 9827128 was granted and assigned to Obalon Therapeutics on November, 2017 by the United States Patent and Trademark Office. | 9827128 | November 28, 2017 | |||||||
Patent 9351862 was granted and assigned to Obalon Therapeutics on May, 2016 by the United States Patent and Trademark Office. | 9351862 | May 31, 2016 | |||||||
Patent 8647358 was granted and assigned to Obalon Therapeutics on February, 2014 by the United States Patent and Trademark Office. | 8647358 | February 11, 2014 | |||||||
Patent 10463520 was granted and assigned to Obalon Therapeutics on November, 2019 by the United States Patent and Trademark Office. | 10463520 | November 5, 2019 | |||||||
Patent 8992561 was granted and assigned to Obalon Therapeutics on March, 2015 by the United States Patent and Trademark Office. | 8992561 | March 31, 2015 | |||||||
Patent 10264995 was granted and assigned to Obalon Therapeutics on April, 2019 by the United States Patent and Trademark Office. | 10264995 | April 23, 2019 | |||||||
Patent 10537453 was granted and assigned to Obalon Therapeutics on January, 2020 by the United States Patent and Trademark Office. | 10537453 | January 21, 2020 | |||||||
Patent 10085865 was granted and assigned to Obalon Therapeutics on October, 2018 by the United States Patent and Trademark Office. | 10085865 | October 2, 2018 | |||||||
Patent 9011477 was granted and assigned to Obalon Therapeutics on April, 2015 by the United States Patent and Trademark Office. | 9011477 | April 21, 2015 | |||||||
Patent 9662239 was granted and assigned to Obalon Therapeutics on May, 2017 by the United States Patent and Trademark Office. | 9662239 | May 30, 2017 | |||||||
Patent 9895248 was granted and assigned to Obalon Therapeutics on February, 2018 by the United States Patent and Trademark Office. | 9895248 | February 20, 2018 | |||||||
Patent 9468550 was granted and assigned to Obalon Therapeutics on October, 2016 by the United States Patent and Trademark Office. | 9468550 | October 18, 2016 | |||||||
Patent 8740927 was granted and assigned to Obalon Therapeutics on June, 2014 by the United States Patent and Trademark Office. | 8740927 | June 3, 2014 | |||||||
Patent 9173758 was granted and assigned to Obalon Therapeutics on November, 2015 by the United States Patent and Trademark Office. | 9173758 | November 3, 2015 | |||||||
Patent 8845674 was granted and assigned to Obalon Therapeutics on September, 2014 by the United States Patent and Trademark Office. | 8845674 | September 30, 2014 | |||||||
Patent 8292911 was granted and assigned to Obalon Therapeutics on October, 2012 by the United States Patent and Trademark Office. | 8292911 | October 23, 2012 | |||||||
Patent 10874537 was granted and assigned to Obalon Therapeutics on December, 2020 by the United States Patent and Trademark Office. | 10874537 | December 29, 2020 |